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TYPE II COLLAGEN PEPTIDE ACTIVATES AKT LEADING TO NF-kB UP-
REGULATION IN OSTEOARTHRITIC CHONDROCYTES
T. Yasuda. Kobe City Med. Ctr. Gen. Hosp., Kobe, Japan
Background of this study: In addition to the proinﬂammatory cyto-
kines, degradation products of cartilage matrix are thought to con-
tribute to joint destruction in osteoarthritis (OA). Excessive degradation
of cartilage matrix in OA involves enhanced cleavage of type II collagen
by collagenases, resulting in denaturation of the triple helix of this
collagen. Denatured and degraded type II collagen leads to an increase
in proteolytic products of type II collagen. Recently, we have found that
a 24-mer synthetic peptide of type II collagen named CB12-II stimulates
type II collagen cleavage with induction of matrix metalloproteinase
(MMP)-13 in association with nuclear factor-kB (NF-kB) activation.
However, intracellular upstream events that cause NF-kB up-regulation
in response to CB12-II remain unclear.
The aim of this study: Akt is a serine/threonine protein kinase that
regulates cell survival signals in response to growth factors and
cytokines. Akt is activated via the phosphoinositide-3-OH kinase
(PI3K) pathway, an important pathway regulating immunity
and inﬂammation. Accumulating evidence indicates that Akt
could stimulate signaling pathways that up-regulate the activity of
NF-kB. Therefore, this study was aimed to elucidate the involvement
of PI3K/Akt pathway in NF-kB activation by CB12-II in OA
chondrocytes.
Methods: OA cartilage specimens were obtained from the distal femur
from patients undergoing total knee replacement surgery. Chon-
drocytes isolated from the OA articular cartilage were cultured in
monolayer with CB12-II. Secreted levels of MMP-13 in conditioned
media were determined with enzyme-linked immunosorbent assay
(ELISA). The cell lysates were used to detect endogenous levels of
phosphorylated Akt and phosphorylated p65 NF-kB by ELISA.
Results: In OA chondrocyte monolayer cultures, CB12-II stimulated
MMP-13 production in associationwith up-regulation of NF-kB and Akt.
Inhibition studies using BAY11-7085 conﬁrmed that MMP-13 pro-
duction by CB12-II was dependent on NF-kB pathway. Similarly,
inhibition studies using LY294002 revealed that MMP-13 production by
CB12-II was dependent on PI3K/Akt pathway. When OA chondrocytes
were preincubated with LY294002, CB12-II-induced levels of phos-
phorylated p65 NF-kB were signiﬁcantly decreased. Thus, NF-kB acti-
vation leading to MMP-13 production requires PI3K/Akt pathway in
CB12-II-stimulated chondrocytes.
Conclusions: This is the ﬁrst study demonstrating that the type II col-
lagen-derived peptide, CB12-II, activates PI3K/Akt pathway leading to
up-regulation of NF-kB. Elucidation of intracellular pathways activated
by type II collagen fragments may be helpful to understand the
pathological process in OA cartilage destruction.
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HYPERCHOLESTEROLEMIA IS A METABOLIC RISK FACTOR FOR
OSTEOARTHRITIS
S. Farnaghi. Inst. of Hlth. and bioMed. innovation, Brisbane, Australia
Purpose: A growing body of evidence suggests that osteoarthritis (OA)
is rather a “metabolic disorder” in which various interrelated metabolic
mediators contribute to the initiation and progression of the disease
process. One such metabolic risk factor could be high cholesterol levels
in the body. The primary objective of this study is to delineate how
abnormal cholesterol levels effects the cartilage biology and its relation
to OA development. Further, in this study we tested whether hyper-
cholesterolemia -induced mitochondrial DNA (mtDNA) damage con-
tributed to increased oxidative stress, mitochondrial dysfunction and
chondrocyte apoptosis.
Methods: We investigate the expression of genes regulating cholesterol
efﬂux (NR1H3 and ABCA1) and inﬂux (SREBF-2 and NPC1L1) in human
chondrocytes that were isolated and graded according to the disease
severity from the patients who were undergoing knee replacement
surgeries. The effect of mtDNA damage on the mRNA expression of
respiratory chain subunits, change of mitochondrial membrane
potential (Djm), overproduction of ROS, and apoptosis were assessed in
high cholesterol-treated ACCs by qRT-PCR, ﬂow cytometry, and confocal
microscopy. The effects of high cholesterol treatment on the human and
bovine cartilage explants were assessed by proteoglycan synthesis and
various biochemical assays.Results: In OA ACCs intracellular levels of cholesterol were higher com-
pared to control group. Furthermore, OA ACCs showed dysregulation of
the balance between cholesterol inﬂux and efﬂux genes. Expression of
cholesterol inﬂuxgenes (SREBF-2 andNPC1L1)were increased inOAACCs
compared to control group. On the other hand, expression of cholesterol
efﬂux genes, ABCA1 and NR1H3 were decreased in OA ACCs (Figure 1A).
We then demonstrated that mtDNA oxidative damage increased rapidly
after high cholesterol (300mM). Accordingly, treatment with high cho-
lesterol resulted in decreasedmembrane potential and overproduction of
ROS inACCs (P< 0.05) and apoptosis (Figure 1B). Interestingly, cholesterol
(300mM) treatment of cartilage explants culture showed an extensive
proteoglycan loss (Figure 1C).MTTanalysis showed thatmetabolic activity
of ACCs was gradually decreased with ascending dose of cholesterol (50,
300, 600mM) stimulation. Protein and mRNA expression level of MMP-13
were increased in cholesterol-stimulated group compared to control;
however, COL2A1 showed different expression trend after cholesterol
treatment. Both protein and mRNA expression level of COL2A1 were
increased in treatment group compared to control (Figure 1C).
Conclusion: mtDNA oxidative damage seems to be the “trigger” for cell
dysfunction in high cholesterol-challenged ACCs by setting in motion
the vicious circle of mtDNA damage leading to ROS overproduction and
further apoptosis resulting in the development of abnormalities that
resemble characteristic features associated with OA.
Fig.1 (A) cholesterol distribution in OA ACCs is higher compared to nor-
mal. (B) Cholesterol treatment induce oxidative stress environment
derived from abnormal mitochondrial function. (C) Cholesterol treatment
challenge cartilage haemostasis.
260
RESVERATROL REGULATES THE WNT/ß-CATENIN PATHWAY IN
HUMAN OSTEOARTHRITIS OSTEOBLASTS
E. Abed, A. Delalandre, J-P. Pelletier, J. Martel-Pelletier, D. Lajeunesse.
CRCHUM, Montreal, QC, Canada
Purpose: Clinical and in vitro studies suggest that subchondral bone
sclerosis due to abnormal osteoblasts (Ob) is involved in the pro-
gression and/or onset of osteoarthritis (OA). Human Ob isolated from
sclerotic subchondral OA bone tissue show an altered phenotype, a
decreased canonical Wnt/ß-catenin signaling pathway (cWnt), and a
reduced mineralization in vitro, alterations linked with an abnormal
response to BMP-2. Recent studies have shown an association between
dietary polyphenols and the prevention of OA. Resveratrol (RSV) is a
polyphenolic phytoestrogen that activates Sirtuin 1, which we pre-
viously showed to be reduced in OA Ob. RSV also stimulates Ob differ-
entiation and may have a positive effect on cartilage protection. RSV
regulates the cWnt pathway in different cell systems and stimulates
BMP-2 expression in human Ob, however, the role of RSV and its effect
in OA Ob remains unknown. Here we investigated the role of RSV in OA
Ob and if it is responsible for their altered response to BMP-2.
Methods: We prepared primary human subchondral Ob using the
sclerotic medial portion of the tibial plateaus of OA patients undergoing
total knee arthroplasty, or from tibial plateaus of normal individuals at
autopsy. The expression of genes was evaluated by qRT-PCR and the
protein production by Western blot analysis. Alkaline phosphatase
activity (ALPase) and osteocalcin release (OC) were measured by
